|
Alpelisib
- 英文名称：Alpelisib
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11138
- cas：1217486-61-7
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-05-16
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11138 |
| 用途 | 科研检测 |
| 英文名称 | Alpelisib |
| 包装规格 | 1MG |
| CAS编号 | 1217486-61-7 |
| 别名 | Alpelisib |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C19H22F3N5O2S
分子量:441.47
溶剂:DMSO (>25 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):PI3K? inhibitor
Function / Pharmacology:Alpelisib is a potent and selective (IC50s = 7.4 nM PI3Kα; 2.2 μM PI3K?; 1.2 μM PI3KIδ; 50-fold selectivity against 442 tested kinases) PI3Kα inhibitor.1 Approved for use in the treatment of HR(+), HER2(-), PIK3CA-mutated breast cancer. Alpelisib has been used in combination with various chemotherapeutics to treat ovarian2, colorectal3, kidney4, bladder5, and head and neck6 cancers.
分子式:C19H22F3N5O2S
分子量:441.47
溶剂:DMSO (>25 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):PI3K? inhibitor
Function / Pharmacology:Alpelisib is a potent and selective (IC50s = 7.4 nM PI3Kα; 2.2 μM PI3K?; 1.2 μM PI3KIδ; 50-fold selectivity against 442 tested kinases) PI3Kα inhibitor.1 Approved for use in the treatment of HR(+), HER2(-), PIK3CA-mutated breast cancer. Alpelisib has been used in combination with various chemotherapeutics to treat ovarian2, colorectal3, kidney4, bladder5, and head and neck6 cancers.
